Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 331

1.

Digital transformation of pharmacists' clinical services.

Spiro S.

J Am Pharm Assoc (2003). 2018 Dec 18. pii: S1544-3191(18)30461-8. doi: 10.1016/j.japh.2018.10.016. [Epub ahead of print]

PMID:
30578127
2.

Gallid herpesvirus 3 SB-1 strain as a recombinant viral vector for poultry vaccination.

Sadigh Y, Powers C, Spiro S, Pedrera M, Broadbent A, Nair V.

NPJ Vaccines. 2018 May 28;3:21. doi: 10.1038/s41541-018-0056-6. eCollection 2018.

3.

Satisfaction Rates and Quality of Life Changes Following Total Knee Arthroplasty in Age-Differentiated Cohorts.

Lange JK, Lee YY, Spiro SK, Haas SB.

J Arthroplasty. 2018 May;33(5):1373-1378. doi: 10.1016/j.arth.2017.12.031. Epub 2017 Dec 29.

PMID:
29395722
4.

Utilizing Dual Mobility Components for First-Time Revision Total Hip Arthroplasty for Instability.

Lange JK, Spiro SK, Westrich GH.

J Arthroplasty. 2018 Feb;33(2):505-509. doi: 10.1016/j.arth.2017.09.029. Epub 2017 Sep 23.

PMID:
29079169
5.

Environmental and Genetic Determinants of Biofilm Formation in Paracoccus denitrificans.

Kumar S, Spiro S.

mSphere. 2017 Sep 6;2(5). pii: e00350-17. doi: 10.1128/mSphereDirect.00350-17. eCollection 2017 Sep-Oct.

6.

Using a non-invasive secure skin closure following total knee arthroplasty leads to fewer wound complications and no patient home care visits compared to surgical staples.

Carli AV, Spiro S, Barlow BT, Haas SB.

Knee. 2017 Oct;24(5):1221-1226. doi: 10.1016/j.knee.2017.07.007. Epub 2017 Aug 7.

PMID:
28797879
7.

Success rates, characteristics, and costs of articulating antibiotic spacers for total knee periprosthetic joint infection.

Nodzo SR, Boyle KK, Spiro S, Nocon AA, Miller AO, Westrich GH.

Knee. 2017 Oct;24(5):1175-1181. doi: 10.1016/j.knee.2017.05.016. Epub 2017 Aug 8.

PMID:
28797875
8.

Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model.

Miller JL, Spiro SG, Dowall SD, Taylor I, Rule A, Alonzi DS, Sayce AC, Wright E, Bentley EM, Thom R, Hall G, Dwek RA, Hewson R, Zitzmann N.

PLoS One. 2016 Nov 23;11(11):e0167018. doi: 10.1371/journal.pone.0167018. eCollection 2016.

9.

Towards improved drug allergy alerts: Multidisciplinary expert recommendations.

Topaz M, Goss F, Blumenthal K, Lai K, Seger DL, Slight SP, Wickner PG, Robinson GA, Fung KW, McClure RC, Spiro S, Acker WW, Bates DW, Zhou L.

Int J Med Inform. 2017 Jan;97:353-355. doi: 10.1016/j.ijmedinf.2016.10.006. Epub 2016 Oct 6. No abstract available.

PMID:
27729200
10.

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.

De Ruysscher D, Lueza B, Le Péchoux C, Johnson DH, O'Brien M, Murray N, Spiro S, Wang X, Takada M, Lebeau B, Blackstock W, Skarlos D, Baas P, Choy H, Price A, Seymour L, Arriagada R, Pignon JP; RTT-SCLC Collaborative Group.

Ann Oncol. 2016 Oct;27(10):1818-28. doi: 10.1093/annonc/mdw263. Epub 2016 Jul 19. Review.

11.

Genome-wide analysis of the response to nitric oxide in uropathogenic Escherichia coli CFT073.

Mehta HH, Liu Y, Zhang MQ, Spiro S.

Microb Genom. 2015 Oct 13;1(4):e000031. doi: 10.1099/mgen.0.000031. eCollection 2015 Oct.

12.

Inefficient translation of nsrR constrains behaviour of the NsrR regulon in Escherichia coli.

Chhabra S, Spiro S.

Microbiology. 2015 Oct;161(10):2029-38. doi: 10.1099/mic.0.000151. Epub 2015 Jul 31.

PMID:
26239124
13.

Research in progress--LungSEARCH: a randomised controlled trial of surveillance for the early detection of lung cancer in a high-risk group.

Spiro SG, Hackshaw A; LungSEARCH Collaborative Group.

Thorax. 2016 Jan;71(1):91-3. doi: 10.1136/thoraxjnl-2015-207433. Epub 2015 Jul 2.

14.

Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial.

Navani N, Nankivell M, Lawrence DR, Lock S, Makker H, Baldwin DR, Stephens RJ, Parmar MK, Spiro SG, Morris S, Janes SM; Lung-BOOST trial investigators.

Lancet Respir Med. 2015 Apr;3(4):282-9. doi: 10.1016/S2213-2600(15)00029-6. Epub 2015 Feb 4.

15.

The European initiative for quality management in lung cancer care.

Blum TG, Rich A, Baldwin D, Beckett P, De Ruysscher D, Faivre-Finn C, Gaga M, Gamarra F, Grigoriu B, Hansen NC, Hubbard R, Huber RM, Jakobsen E, Jovanovic D, Konsoulova A, Kollmeier J, Massard G, McPhelim J, Meert AP, Milroy R, Paesmans M, Peake M, Putora PM, Scherpereel A, Schönfeld N, Sitter H, Skaug K, Spiro S, Strand TE, Taright S, Thomas M, van Schil PE, Vansteenkiste JF, Wiewrodt R, Sculier JP.

Eur Respir J. 2014 May;43(5):1254-77. doi: 10.1183/09031936.00106913. Epub 2014 Mar 23.

16.

Children must be protected from the tobacco industry's marketing tactics.

Hopkinson N, Wallis C, Higgins B, Gaduzo S, Sherrington R, Keilty S, Stern M, Britton J, Bush A, Moxham J, Sylvester K, Griffiths V, Sutherland T, Crossingham I, Raju R, Spencer C, Safavi S, Deegan P, Seymour J, Hickman K, Hughes J, Wieboldt J, Shaheen F, Peedell C, Mackenzie N, Nicholl D, Jolley C, Crooks G, Crooks G, Dow C, Deveson P, Bintcliffe O, Gray B, Kumar S, Haney S, Docherty M, Thomas A, Chua F, Dwarakanath A, Summers G, Prowse K, Lytton S, Ong YE, Graves J, Banerjee T, English P, Leonard A, Brunet M, Chaudhry N, Ketchell RI, Cummings N, Lebus J, Sharp C, Meadows C, Harle A, Stewart T, Parry D, Templeton-Wright S, Moore-Gillon J, Stratford- Martin J, Saini S, Matusiewicz S, Merritt S, Dowson L, Satkunam K, Hodgson L, Suh ES, Durrington H, Browne E, Walters N, Steier J, Barry S, Griffiths M, Hart N, Nikolic M, Berry M, Thomas A, Miller J, McNicholl D, Marsden P, Warwick G, Barr L, Adeboyeku D, Mohd Noh MS, Griffiths P, Davies L, Quint J, Lyall R, Shribman J, Collins A, Goldman J, Bloch S, Gill A, Man W, Christopher A, Yasso R, Rajhan A, Shrikrishna D, Moore C, Absalom G, Booton R, Fowler RW, Mackinlay C, Sapey E, Lock S, Walker P, Jha A, Satia I, Bradley B, Mustfa N, Haqqee R, Thomas M, Patel A, Redington A, Pillai A, Keaney N, Fowler S, Lowe L, Brennan A, Morrison D, Murray C, Hankinson J, Dutta P, Maddocks M, Pengo M, Curtis K, Rafferty G, Hutchinson J, Whitfield R, Turner S, Breen R, Naveed SU, Goode C, Esterbrook G, Ahmed L, Walker W, Ford D, Connett G, Davidson P, Elston W, Stanton A, Morgan D, Myerson J, Maxwell D, Harrris A, Parmar S, Houghton C, Winter R, Puthucheary Z, Thomson F, Sturney S, Harvey J, Haslam PL, Patel I, Jennings D, Range S, Mallia-Milanes B, Collett A, Tate P, Russell R, Feary J, O'Driscoll R, Eaden J, Round J, Sharkey E, Montgomery M, Vaughan S, Scheele K, Lithgow A, Partridge S, Chavasse R, Restrick L, Agrawal S, Abdallah S, Lacy-Colson A, Adams N, Mitchell S, Haja Mydin H, Ward A, Denniston S, Steel M, Ghosh D, Connellan S, Rigge L, Williams R, Grove A, Anwar S, Dobson L, Hosker H, Stableforth D, Greening N, Howell T, Casswell G, Davies S, Tunnicliffe G, Mitchelmore P, Phitidis E, Robinson L, Prowse K, Bafadhel M, Robinson G, Boland A, Lipman M, Bourke S, Kaul S, Cowie C, Forrest I, Starren E, Burke H, Furness J, Bhowmik A, Everett C, Seaton D, Holmes S, Doe S, Parker S, Graham A, Paterson I, Maqsood U, Ohri C, Iles P, Kemp S, Iftikhar A, Carlin C, Fletcher T, Emerson P, Beasley V, Ramsay M, Buttery R, Mungall S, Crooks S, Ridyard J, Ross D, Guadagno A, Holden E, Coutts I, Cullen K, O'Connor S, Barker J, Sloper K, Watson J, Smith P, Anderson P, Brown L, Nyman C, Milburn H, Clive A, Serlin M, Bolton C, Fuld J, Powell H, Dayer M, Woolhouse I, Georgiadi A, Leonard H, Dodd J, Campbell I, Ruiz G, Zurek A, Paton JY, Malin A, Wood F, Hynes G, Connell D, Spencer D, Brown S, Smith D, Cooper D, O'Kane C, Hicks A, Creagh-Brown B, Lordan J, Nickol A, Primhak R, Fleming L, Powrie D, Brown J, Zoumot Z, Elkin S, Szram J, Scaffardi A, Marshall R, Macdonald I, Lightbody D, Farmer R, Wheatley I, Radnan P, Lane I, Booth A, Tilbrook S, Capstick T, Hewitt L, McHugh M, Nelson C, Wilson P, Padmanaban V, White J, Davison J, O'Callaghan U, Hodson M, Edwards J, Campbell C, Ward S, Wooler E, Ringrose E, Bridges D, Matthew Hodson, John Edwards, Colin Campbell, Simon Ward, Edwina Wooler, Elizabeth Ringrose, Diana Bridges, Rosalind Backham, Kim Randall, Tracey Mathieson, Long A, Parkes M, Clarke S, Allen B, Connelly C, Forster G, Hoadley J, Martin K, Barnham K, Khan K, Munday M, Edwards C, O'Hara D, Turner S, Pieri-Davies S, Ford K, Daniels T, Wright J, Towns R, Fern K, Butcher J, Burgin K, Winter B, Freeman D, Olive S, Gray L, Pye K, Roots D, Cox N, Davies CA, Wicker J, Hilton K, Lloyd J, MacBean V, Wood M, Kowal J, Downs J, Ryan H, Guyatt F, Nicoll D, Lyons E, Narasimhan D, Rodman A, Walmsley S, Newey A, Buxton M, Dewar M, Cooper A, Reilly J, Lloyd J, Macmillan AB, Roots D, Olley A, Voase N, Martin S, McCarvill I, Christensen A, Agate R, Heslop K, Timlett A, Hailes K, Davey C, Pawulska B, Lane A, Ioakim S, Hough A, Treharne J, Jones H, Winter-Burke A, Miller L, Connolly B, Bingham L, Fraser U, Bott J, Johnston C, Graham A, Curry D, Sumner H, Costello CA, Bartoszewicz C, Badman R, Williamson K, Taylor A, Purcell H, Barnett E, Molloy A, Crawfurd L, Collins N, Monaghan V, Mir M, Lord V, Stocks J, Edwards A, Greenhalgh T, Lenney W, McKee M, McAuley D, Majeed A, Cookson J, Baker E, Janes S, Wedzicha W, Lomas Dean D, Harrison B, Davison T, Calverley P, Wilson R, Stockley R, Ayres J, Gibson J, Simpson J, Burge S, Warner J, Lenney W, Thomson N, Davies P, Woodcock A, Woodhead M, Spiro S, Ormerod L, Bothamley G, Partridge M, Shields M, Montgomery H, Simonds A, Barnes P, Durham S, Malone S, Arabnia G, Olivier S, Gardiner K, Edwards S.

BMJ. 2013 Dec 9;347:f7358. doi: 10.1136/bmj.f7358. No abstract available.

17.

Finely tuned regulation of the aromatic amine degradation pathway in Escherichia coli.

Zeng J, Spiro S.

J Bacteriol. 2013 Nov;195(22):5141-50. doi: 10.1128/JB.00837-13. Epub 2013 Sep 6.

18.

Cooperative and allosterically controlled nucleotide binding regulates the DNA binding activity of NrdR.

McKethan BL, Spiro S.

Mol Microbiol. 2013 Oct;90(2):278-89. doi: 10.1111/mmi.12364. Epub 2013 Aug 28.

19.

Tobacco industry lobbyists and their health-care clients.

Hopkinson NS, Moxham J, Montgomery H, West R, Scally G, McKee M, Spiro S, Bush A, Stradling J, Wells A, Chung KF, Durham SR, Martin FC, Congleton J, Roddy E, Dayer M, White P, Ind PW, Brown JL, Patel I, Lewis K, Hart N, Kemp S, Barker J, Hind M, Nicholl D, Stern M, Elkin S.

Lancet. 2013 Feb 9;381(9865):445. doi: 10.1016/S0140-6736(13)60236-6. No abstract available.

PMID:
23399061
20.

Genome-wide mapping of the binding sites of proteins that interact with DNA.

Spiro S.

Methods Mol Biol. 2012;881:137-56. doi: 10.1007/978-1-61779-827-6_6.

PMID:
22639213
21.

Nitrous oxide production and consumption: regulation of gene expression by gas-sensitive transcription factors.

Spiro S.

Philos Trans R Soc Lond B Biol Sci. 2012 May 5;367(1593):1213-25. doi: 10.1098/rstb.2011.0309. Review.

22.

Screening for lung cancer: we still need to know more.

Spiro SG.

Thorax. 2012 Apr;67(4):283-5. doi: 10.1136/thoraxjnl-2011-201541. Epub 2012 Feb 14. No abstract available.

PMID:
22334533
23.

Non-heme iron sensors of reactive oxygen and nitrogen species.

Spiro S, D'Autréaux B.

Antioxid Redox Signal. 2012 Nov 1;17(9):1264-76. doi: 10.1089/ars.2012.4533. Epub 2012 Mar 8. Review.

PMID:
22304730
24.

Screening for lung cancer: is this the way forward?

Spiro SG, Navani N.

Respirology. 2012 Feb;17(2):237-46. doi: 10.1111/j.1440-1843.2011.02114.x. Review.

PMID:
22142440
25.

Attitudes to participation in a lung cancer screening trial: a qualitative study.

Patel D, Akporobaro A, Chinyanganya N, Hackshaw A, Seale C, Spiro SG, Griffiths C; Lung-SEARCH Investigators.

Thorax. 2012 May;67(5):418-25. doi: 10.1136/thoraxjnl-2011-200055. Epub 2011 Nov 21.

PMID:
22106018
26.

Another target for NO.

Spiro S.

Cell Host Microbe. 2011 Jul 21;10(1):1-2. doi: 10.1016/j.chom.2011.07.001.

27.

Health information technology: how we got where we are.

McSpadden C, Spiro S.

Consult Pharm. 2011 Mar;26(3):156-64, 167-9. doi: 10.4140/TCP.n.2011.156.

PMID:
21402516
28.

Year in review 2010: tuberculosis, pleural diseases, respiratory infections.

Leung CC, Feller-Kopman D, Niederman MS, Spiro SG.

Respirology. 2011 Apr;16(3):564-73. doi: 10.1111/j.1440-1843.2011.01940.x. Review. No abstract available.

PMID:
21276133
29.

PET scanning is important in lung cancer; but it has its limitations.

Navani N, Spiro SG.

Respirology. 2010 Nov;15(8):1149-51. doi: 10.1111/j.1440-1843.2010.01843.x. No abstract available.

PMID:
20920122
30.

Vibrio fischeri flavohaemoglobin protects against nitric oxide during initiation of the squid-Vibrio symbiosis.

Wang Y, Dunn AK, Wilneff J, McFall-Ngai MJ, Spiro S, Ruby EG.

Mol Microbiol. 2010 Nov;78(4):903-15. doi: 10.1111/j.1365-2958.2010.07376.x. Epub 2010 Sep 29.

31.

An alternative route to nitric oxide resistance.

Spiro S.

Mol Microbiol. 2010 Jul 1;77(1):6-10. doi: 10.1111/j.1365-2958.2010.07195.x. Epub 2010 May 4. Review.

32.

Down-regulation of the Escherichia coli K-12 nrf promoter by binding of the NsrR nitric oxide-sensing transcription repressor to an upstream site.

Browning DF, Lee DJ, Spiro S, Busby SJ.

J Bacteriol. 2010 Jul;192(14):3824-8. doi: 10.1128/JB.00218-10. Epub 2010 May 14.

33.

Year in review 2009: Respiratory infections, tuberculosis, pleural diseases and lung cancer.

Spiro SG, Niederman M, Yew WW, Porcel JM.

Respirology. 2010 Apr;15(3):562-72. doi: 10.1111/j.1440-1843.2010.01725.x. Epub 2010 Mar 19. Review. No abstract available.

PMID:
20337992
34.

Lung cancer: progress in diagnosis, staging and therapy.

Spiro SG, Tanner NT, Silvestri GA, Janes SM, Lim E, Vansteenkiste JF, Pirker R.

Respirology. 2010 Jan;15(1):44-50. doi: 10.1111/j.1440-1843.2009.01674.x. Review.

PMID:
20199634
35.

Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.

Douillard JY, Tribodet H, Aubert D, Shepherd FA, Rosell R, Ding K, Veillard AS, Seymour L, Le Chevalier T, Spiro S, Stephens R, Pignon JP; LACE Collaborative Group.

J Thorac Oncol. 2010 Feb;5(2):220-8. doi: 10.1097/JTO.0b013e3181c814e7.

36.

Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancer.

Lee SM, Rudd R, Woll PJ, Ottensmeier C, Gilligan D, Price A, Spiro S, Gower N, Jitlal M, Hackshaw A.

J Clin Oncol. 2009 Nov 1;27(31):5248-54. doi: 10.1200/JCO.2009.21.9733. Epub 2009 Sep 21.

PMID:
19770378
37.

NsrR targets in the Escherichia coli genome: new insights into DNA sequence requirements for binding and a role for NsrR in the regulation of motility.

Partridge JD, Bodenmiller DM, Humphrys MS, Spiro S.

Mol Microbiol. 2009 Aug;73(4):680-94. doi: 10.1111/j.1365-2958.2009.06799.x. Epub 2009 Jul 27.

38.

Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial.

Lee SM, Woll PJ, Rudd R, Ferry D, O'Brien M, Middleton G, Spiro S, James L, Ali K, Jitlal M, Hackshaw A.

J Natl Cancer Inst. 2009 Aug 5;101(15):1049-57. doi: 10.1093/jnci/djp200. Epub 2009 Jul 16.

PMID:
19608997
39.

EBUS-TBNA for the mediastinal staging of non-small cell lung cancer.

Navani N, Spiro SG, Janes SM.

J Thorac Oncol. 2009 Jun;4(6):776; author reply 776-7. doi: 10.1097/JTO.0b013e3181a52e4d. No abstract available.

40.

Mediastinal staging of NSCLC with endoscopic and endobronchial ultrasound.

Navani N, Spiro SG, Janes SM.

Nat Rev Clin Oncol. 2009 May;6(5):278-86. doi: 10.1038/nrclinonc.2009.39. Review.

41.

Metalloregulatory proteins and nitric oxide signalling in bacteria.

Spiro S.

Biochem Soc Trans. 2008 Dec;36(Pt 6):1160-4. doi: 10.1042/BST0361160. Review.

PMID:
19021516
42.

Respiratory education: a dangerous drift away from academia?

Polkey M, Howes T, Burns G, Spiro SG.

Eur Respir J. 2008 Nov;32(5):1144-5. doi: 10.1183/09031936.00137008. No abstract available.

43.

Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer.

Lee SM, James LE, Qian W, Spiro S, Eisen T, Gower NH, Ferry DR, Gilligan D, Harper PG, Prendiville J, Hocking M, Rudd RM.

Thorax. 2009 Jan;64(1):75-80. doi: 10.1136/thx.2007.093872. Epub 2008 Sep 11.

PMID:
18786981
44.

Escherichia coli NsrR regulates a pathway for the oxidation of 3-nitrotyramine to 4-hydroxy-3-nitrophenylacetate.

Rankin LD, Bodenmiller DM, Partridge JD, Nishino SF, Spain JC, Spiro S.

J Bacteriol. 2008 Sep;190(18):6170-7. doi: 10.1128/JB.00508-08. Epub 2008 Jul 25.

45.

Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.

Früh M, Rolland E, Pignon JP, Seymour L, Ding K, Tribodet H, Winton T, Le Chevalier T, Scagliotti GV, Douillard JY, Spiro S, Shepherd FA.

J Clin Oncol. 2008 Jul 20;26(21):3573-81. doi: 10.1200/JCO.2008.16.2727.

PMID:
18640938
46.

Lung cancer staging with minimally invasive endoscopic techniques.

Navani N, Janes SM, Spiro SG.

JAMA. 2008 Jun 4;299(21):2509; author reply 2510-1. doi: 10.1001/jama.299.21.2509-a. No abstract available.

PMID:
18523214
47.

Complications of lung cancer treatment.

Spiro SG, Douse J, Read C, Janes S.

Semin Respir Crit Care Med. 2008 Jun;29(3):302-17. doi: 10.1055/s-2008-1076750. Review.

PMID:
18506668
48.

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Le Chevalier T; LACE Collaborative Group.

J Clin Oncol. 2008 Jul 20;26(21):3552-9. doi: 10.1200/JCO.2007.13.9030. Epub 2008 May 27.

PMID:
18506026
49.

Characterization of the nitric oxide-reactive transcriptional activator NorR.

D'Autréaux B, Tucker N, Spiro S, Dixon R.

Methods Enzymol. 2008;437:235-51. doi: 10.1016/S0076-6879(07)37013-4. Review.

PMID:
18433632
50.

Genome-wide identification of binding sites for the nitric oxide-sensitive transcriptional regulator NsrR.

Efromovich S, Grainger D, Bodenmiller D, Spiro S.

Methods Enzymol. 2008;437:211-33. doi: 10.1016/S0076-6879(07)37012-2. Review.

PMID:
18433631

Supplemental Content

Support Center